Merck in Medical News

Covance to Acquire Seattle-Based Gene Expression Laboratory from Merck & Co., Inc.

PRINCETON, N.J., July 29 /PRNewswire-FirstCall/ -- Covance (NYSE: CVD ) today announced it has entered into a definitive agreement with Merck & Co., Inc. relating to the supply of genomic analysis services. Under the terms of the agreement Merck has committed to ...

Cardiome Achieves Milestone From Collaboration With Merck Co., Inc.

NASDAQ: CRME TSX: COM VANCOUVER, July 28 /PRNewswire-FirstCall/ - Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) today announced that it has earned a US$15 million milestone payment from its collaboration with Merck Co., Inc., through an affiliate. The milestone was triggered by th...

Neuromed Announces that Merck & Co., Inc. Terminates Research Collaboration and License Agreement for Compounds Targeting N-Type Calcium Channels

CONSHOHOCKEN, PA and VANCOUVER, BC, June 11 /PRNewswire/ - Neuromed Pharmaceuticals Ltd. announced today that it has received notification that Merck & Co., Inc. will terminate the research collaboration and license agreement for novel compounds targeting N-type calcium channels for the treatm...

Xenon Enters Cardiovascular Disease Collaboration With Merck & Co., Inc.

VANCOUVER, Canada, June 11 /PRNewswire/ -- Xenon today announced a strategic alliance with Merck & Co., Inc., through an affiliate, to discover and develop novel small molecule candidates for the potential treatment of cardiovascular disease. "We are very excited to be collaborating with ...

Cardiome Announces That Collaboration and License Agreement with Merck & Co., Inc. Now Effective

NASDAQ: CRME TSX: COM VANCOUVER, May 19 /PRNewswire-FirstCall/ - Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) today announced that the waiting period under the Hart-Scott-Rodino Act for the collaboration and license agreement with Merck & Co., Inc. and a Merck affiliate for d...

Gene Network Sciences Names Departing Merck Head of Genetics Eric Schadt as Co-Chair of Scientific Advisory Board

CAMBRIDGE, Mass., April 7 /PRNewswire/ -- Gene Network Sciences, Inc. today announced that it named Dr. Eric Schadt, a leading researcher in the field of genomics-driven drug discovery, co-chair of its Scientific Advisory Board. Dr. Schadt will be leaving his position as Executive Scienti...

Insmed Completes Sale of Follow-On Biologics Platform to Merck & Co., Inc. for Gross Proceeds of $130 Million

RICHMOND, Va., March 31 /PRNewswire-FirstCall/ -- Insmed Inc. (Nasdaq: INSM ), a biopharmaceutical company, announced today that it has successfully closed the sale of all of the Company's assets related to its follow-on biologics business to a subsidiary of Merck & Co., Inc. As a result of...

Former Merck Executive Joins Board of Clinical Information Network, Inc.

SCOTTSDALE, Ariz., March 19 /PRNewswire/ -- Clinical Information Network, Inc., the Video Detailing company, announced today that Robert J. LaBuda has joined its board of directors. Until establishing his own company in late 2008, LaBuda was the executive at Merck responsible for the successf...

The Merck Company Foundation Launches Five-Year Effort to Close Healthcare Disparity Gaps

New Alliance Aims to Reduce Disparities in Diabetes Prevention and Management Among Most At-Risk Populations WASHINGTON, Feb. 25 /PRNewswire-USNewswire/ -- The Merck Company Foundation (Foundation), the philanthropic arm of Merck & Co., Inc., today announced the launch of The Alliance to ...

Arena Pharmaceuticals Announces Initiation by Merck of Phase 2 Clinical Trial of Niacin Receptor Agonist

SAN DIEGO, Feb. 18 /PRNewswire-FirstCall/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA ) announced today the initiation of a Phase 2 clinical trial of an orally administered niacin receptor agonist drug candidate being developed by Merck & Co., Inc., under its collaboration with Arena to t...

Drugs from Biogen Idec and Merck are the Most Promising Therapies in Development in the Acute Heart Failure Market

Overall Market for Acute Heart Failure Therapies Will More Than Double to $768 Million in 2017, According to a New Report from Decision Resources WALTHAM, Mass., Feb. 2 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare...

Clarus Ventures Hires Former Merck President Ed Scolnick and Broad Institute Scientist Finny Kuruvilla

CAMBRIDGE, Mass. and SOUTH SAN FRANCISCO, Calif., Jan. 5 /PRNewswire/ -- Clarus Ventures, LLC ("Clarus Ventures"), a leading life sciences venture capital firm, announced today the hiring of Edward Scolnick, M.D., as a Venture Partner and Finny Kuruvilla, M.D., Ph.D., as a Principal in the Firm's ...

ARVO Foundation and Merck to provide prestigious global ophthalmic research award

Rockville, MD -- The ARVO Foundation for Eye Research (AFER) and Merck & Co., Inc. are pleased to announce a series of awards that honor young scientists throughout the world for their innovative contributions to ophthalmology research. Each award cycle is worth a total of $70,000 in grants. Th...

Merck KGaA and Nano-Terra Announce Extension of Nanotechnology Solutions Alliance

Merck KGaA (EMD in North America) announced today the extension of its existing strategic alliance with Nano-Terra, Inc., a leading nanotechnology co-development company. DARMSTADT, Germany (Business Wire EON) October 7, 2008 -- The original agreement between the comp...

Covance Recognized for Outstanding Performance by Merck & Co., Inc.

PRINCETON, N.J., July 31 /PRNewswire-FirstCall/ -- Covance Inc. (NYSE: CVD), a leading provider of drug development services, today announced that its central laboratory services received Merck & Co., Inc.'s Outstanding Strategic Collaboration Award. Covance Central Laboratory Services is on...

Schering-Plough and Merck Announce Withdrawal of Loratadine/Montelukast NDA and Termination of Respiratory Joint Venture

KENILWORTH and WHITEHOUSE STATION, N.J., June 27 /PRNewswire-FirstCall/ -- Schering-Plough Corp. (NYSE: SGP ) and Merck & Co., Inc. (NYSE: MRK ) announce the withdrawal of the New Drug Application (NDA) for the loratadine/montelukast combination tablet. The companies also terminated the Sc...

Schiffrin Barroway Topaz & Kessler, LLP Announces Court Ruling Relating to Merck & Co. Inc.'s Employee Savings & Security Plan, the Merck & Co., Inc. Employee Stock Purchase & Savings Plan, and the Merck Puerto Rico Employee Savings & Security Plan

RADNOR, Pa., June 19 /PRNewswire/ -- ADVERTISEMENT - The following statement was issued today by the law firm of Schiffrin Barroway Topaz & Kessler, LLP: Schiffrin Barroway Topaz & Kessler, LLP is Co-Lead Counsel for the ERISA plaintiffs in the In re Merck & Co. Inc. Securities, Derivative, ...

Novartis, Pfizer and Merck Take the Lead on Strong Relationships with Physicians, as Doctors Demand an Expanding Set of Services

NEW YORK, June 17 /PRNewswire/ -- Among US primary care physicians, Novartis earns the highest sales rep relationship scores, followed by Pfizer, Merck, GlaxoSmithKline and Sanofi-Aventis, according to new research from TNS Healthcare. Novartis also takes the top spot in Europe, demonstrating ...

UNICEF & Merck Partner to Protect 100,000 Children and Young People Against Mumps Epidemic

NEW YORK, June 9 /PRNewswire-USNewswire/ -- Officials with the U.S. Fund for UNICEF and global pharmaceutical company, Merck & Co., Inc. announced the donation and delivery of 100,000 doses of M-M-R(R) II (measles, mumps and rubella virus vaccine, live, attenuated) to the government of the for...

Healthy Interactions and Merck Announce Further Collaboration to Transform Diabetes Education in the U.S.

U.S. Diabetes Conversation Map(R) Program to Expand in General Market and Launch in Spanish CHICAGO and WHITEHOUSE STATION, N.J., June 5 /PRNewswire/ -- Healthy Interactions Inc., a global leader in health education, and Merck & Co., Inc., a global research-driven phar...

Mylan Inc. Acquires Central Eastern European Generics Businesses of Merck KGaA

PITTSBURGH, June 2 /PRNewswire-FirstCall/ -- Mylan Inc. (NYSE: MYL ) today announced that it has acquired Merck KGaA's Central & Eastern Europe (CEE) generics businesses, which include operations in Poland, Hungary, Slovakia, Slovenia and the Czech Republic. As announced previously, Mylan exe...

Pennsylvania Attorney General Corbett Announces a Multi-state, $58 Million Settlement With Merck Over Deceptive Advertising Concerning the Safety of Vioxx

HARRISBURG, Pa., May 20 /PRNewswire-USNewswire/ -- Pennsylvania, along with 28 other states and the District of Columbia, reached a $58 million settlement, the largest ever for a multi-state consumer protection drug case, with Merck over allegations of deceptive advertising related to the drug...

Law Offices of Howard G. Smith Announces Investigation on Behalf of Current and Former Employees of Merck & Co., Inc. Who Invested in the Merck & Co., Inc. Employee Savings and Security Plan

BENSALEM, Pa., April 9 /PRNewswire/ -- Law Offices of Howard G. Smith announces that it is investigating claims against Merck & Co., Inc. ("Merck" or the "Company")(NYSE: MRK ) concerning whether the Company's Employee Savings and Security Plan (the "Plan") imprudently invested in Merck stock...

CORRECTED: Hagens Berman Sobol Shapiro Files Suit Against Merck and Schering-Plough

Lawsuit claims companies knowingly misled consumers on the use of Zetia and Vytorin. NEWARK, N.J., Jan. 24 /PRNewswire/ -- Hagens Berman Sobol Shapiro filed a proposed class-action lawsuit against Merck (NYSE: MRK ) and Schering-Plough (NYSE: SGP ), manufacturers...

Lawsuit Filed in Florida Federal Court Over Marketing of Vytorin and Zetia By Merck and Schering-Plough

Lawsuit alleges violations of consumer statutes, breach of warranty and unjust enrichment; Damages would involve return of proceeds from sales in excess of $5 billion last year, mostly paid through Medicare, Medicaid, other federal drug programs and private insurance JACKSONVILLE,...

BioMarin Re-Acquires Rights to Kuvan in Canada From Merck Serono

NOVATO, Calif., Dec. 18 /PRNewswire-FirstCall/ -- BioMarin Pharmaceutical Inc. (Nasdaq and SWX: BMRN) announced today that it has re-acquired the Canadian rights for tetrahydrobiopterin (BH4), including Kuvan(TM) (sapropterin dihydrochloride), from Merck Serono, a division of Merck KGaA, Darms...

ICx Technologies Works With Merck & Co., Inc. to Develop Cancer Diagnostic Technology

WASHINGTON and LA JOLLA, Calif., Dec. 3 /PRNewswire-FirstCall/ -- ICx Technologies (Nasdaq: ICXT ), a developer of advanced technology solutions for homeland security and force protection, announced today a research study with Merck & Co., Inc. and Fred Hutchinson Cancer Research Center of Se...

GlaxoSmithKline Obtains Exclusive U.S. OTC Marketing Rights to MEVACOR(R) (lovastatin) from Merck & Co., Inc.

Following FDA Approval, Agreement will Broaden Access to Cholesterol-Reducing Medicine PHILADELPHIA and WHITEHOUSE STATION, N.J., Nov. 26 /PRNewswire/ -- GlaxoSmithKline, Philadelphia, PA, USA (GSK) and Merck & Co., Inc., Whitehouse Station, NJ, USA (Merck), announc...

The Lanier Law Firm Announces $4.85 Billion National Vioxx Settlement With Merck & Co. Inc.

Mark Lanier, winner of nation's first Vioxx trial, hails settlement as 'the right thing to do' HOUSTON, Nov. 9 /PRNewswire/ -- Attorneys from The Lanier Law Firm are announcing a nationwide settlement agreement with pharmaceutical giant Merck & Co. Inc. (NYSE: MRK ) th...

Dynavax and Merck & Co., Inc. Announce Partnership to Develop HEPLISAV(TM), an Investigational Hepatitis B Vaccine Currently in Phase 3

BERKELEY, Calif., and WHITEHOUSE STATION, N.J., Nov. 1 /PRNewswire-FirstCall/ -- Dynavax Technologies Corporation (Nasdaq: DVAX ) and Merck & Co., Inc. (NYSE: MRK ) today announced a global license and development collaboration agreement to jointly develop HEPLISAV(TM), a novel investigation...

ImClone and Bristol-Myers Squibb Announce Joint Agreement With Merck KGaA to Co-Develop and Co-Commercialize ERBITUX(R) in Japan

NEW YORK, Oct. 17 /PRNewswire-FirstCall/ -- ImClone Systems Incorporated (Nasdaq: IMCL ) and Bristol-Myers Squibb Company (NYSE: BMY ) today announced that they have established an agreement with Merck KGaA for the co-development and co-commercialization of ERBITUX(R) (cetuximab) in Japan. U...

AHF Challenges Merck Over Steep Price of Its New AIDS Drug, Isentress

Company Prices New HIV/AIDS Salvage Drug at $9,900 USD Per Patient Yearly Following FDA's Recent Approval of Isentress, Merck's New Integrase Inhibitor. AHF Decries Overall Price Spiral on New AIDS Drugs; Urges Restraint by Entire Pharmaceutical Industry in Pricing LOS ANGELES, Oct. 15 /PRNe...

Mylan Vice Chairman and CEO Robert J. Coury to Ring NYSE Closing Bell(R) in Celebration of Merck Generics Acquisition

PITTSBURGH, Oct. 4 /PRNewswire-FirstCall/ -- Mylan (NYSE: MYL ) announced today that its Vice Chairman and CEO Robert J. Coury is scheduled to ring The Closing Bell(R) on the New York Stock Exchange (NYSE) at 4 p.m. today, Thursday, Oct. 4, 2007, in celebration of the Company's acquisition of...

The African Medical and Research Foundation (AMREF) Honors Merck & Co., Inc. with Global Corporate Philanthropy Award

AMREF Founder Tom Rees Honored with Humanitarian Award NEW YORK, Sept. 17 /PRNewswire/ -- The African Medical and Research Foundation (AMREF) will bestow its annual Global Corporate Philanthropy Award on the research-driven pharmaceutical company Merck & Co., Inc., here tonight during...

Schering-Plough Reports Proposed Settlement in Litigation Involving Planned Merger with Merck

KENILWORTH, N.J., July 24 /PRNewswire-FirstCall/ -- Schering-Plough Corporation (NYSE: SGP ) today reported a proposed settlement, subject to Court approval, to resolve litigation seeking to enjoin the planned merger with Merck & Co., Inc., and other forms of relief. The consolidated c...

PAREXEL Enhances Study Start-Up and Recruitment Capabilities With Appointment of Dr. Lars-Olof Eriksson, Formerly With Merck

BOSTON, June 11 /PRNewswire-FirstCall/ -- PAREXEL International Corporation (Nasdaq: PRXL ), a leading global biopharmaceutical services provider, has appointed Lars-Olof Eriksson, Ph.D., MS.c., to the position of Vice President of its Start-up and Accelerated Recruitment Team (START). Formerly ...

NYC Benefit Raises $1.4m for the Damon Runyon Cancer Research Foundation, Honors Merck

NEW YORK, June 4 /PRNewswire-USNewswire/ -- A charity breakfast at New York's Rainbow Room on May 27th raised $1.4 million for innovative cancer research funded by the Damon Runyon Cancer Research Foundation . The Foundation gives 100% of donations to exceptional early-career cancer resear...

Hagens Berman Appointed Co-Lead Counsel in Case Against Schering-Plough and Merck

Lawsuit claims manufacturers misled consumers about the use of Zetia and Vytorin. SEATTLE, June 10 /PRNewswire/ -- Last week the U.S. District Court in New Jersey appointed Hagens Berman, along with four other firms, co-counsel in a case against Schering-Plough (...

Brazil Government In Contention With Merck Over Anti-AIDS Drug

The Brazil government is up against giant drug manufacturers- Merck &Co. The issue in contention is the pricey anti-AIDS drug Efavirenz. According to the Brazilian government, there is no call to charge as much as 1.59 US dollars for a 600mg pill when Thailand is paying 65 cents for the same. ...

Brazil Government In Contention With Merck Over Anti-AIDS Drug

The Brazil government is up against giant drug manufacturers- Merck &Co. //The issue in contention is the ‘pricey’ anti-AIDS drug Efavirenz. According to the Brazilian government, there is no call to charge as much as 1.59 US dollars for a 600mg pill when Thailand is paying 65 cents for the same. ...